Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 1, 2009, Pages 29-35

  Wakabayashi, Ichiro ^a,b   Masuda, Hiroshi ^c  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c Department of Internal Medicine   (Japan)

Author keywords

Atherosclerosis; Blood coagulation; Blood fibrinolysis; D dimer; Diabetes mellitus; Microalbuminuria

Indexed keywords

ALBUMIN; ALPHA 2 ANTIPLASMIN; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CREATININE; D DIMER; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; URIC ACID;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE PRESSURE; SEX; THROMBOCYTE; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; CAROTID ARTERIES; CHOLESTEROL, HDL; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOPHILIA; URIC ACID;

EID: 60649093504     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0155-0     Document Type: Article

References (36)

1. Parving HH (1996) Microalbuminuria in essential hypertension and diabetes mellitus. J Hypertens Suppl 14:S89-S93
2. Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413-1418
3. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360
4. Parving HH, Oxenbøll B, Svendsen PA, Christiansen JS, Andersen AR (1982) Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100:550-555
5. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC (1992) Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study. Kidney Int 41:836-839
6. Guerrero-Romero F, Rodríguez-Morán M (1999) Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus. Stroke 30:1787-1791
7. Gerstein HC, Mann JF, Yi Q et al, HOPE Study Investigators (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426
8. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS (1999) Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19:1992-1997
9. Wachtell K, Ibsen H, Olsen MH et al (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study. Ann Intern Med 139:901-906
10. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR (1990) Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. Am Heart J 120:672-676
11. Ganda OP, Arkin CF (1992) Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care 15:1245-1250
12. Ceriello A (1993) Coagulation activation in diabetes mellitus: The role of hyperglycaemia and therapeutic prospects. Diabetologia 36:1119-1125
13. Gabazza EC, Takeya H, Deguchi H et al (1996) Protein C activation in NIDDM patients. Diabetologia 39:1455-1461
14. Myrup B, de Maat M, Rossing P, Gram J, Kluft C, Jespersen J (1996) Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res 81:485-490
15. Shimizu H, Ohtani K, Tanaka Y et al (1995) Increased plasma thrombin-antithrombin III complex levels in non-insulin dependent diabetic patients with albuminuria are reduced by ethyl icosapentatenoate. Thromb Haemost 74:1231-1234
16. Knöbl P, Schernthaner G, Schnack C et al (1993) Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1045-1050
17. Kario K, Sakata T, Matsuo T, Miyata T (1993) Factor VII in non-insulin-dependent diabetic patients with microalbuminuria. Lancet 342:1552
18. Asakawa H, Tokunaga K, Kawakami F (2000) Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabetes Complications 14:121-126
19. Agewall S, Lindstedt G, Fagerberg B (2001) Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men. Atherosclerosis 157:197-202
20. Agewall S, Fagerberg B, Attvall S et al (1995) Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group. J Intern Med 237:195-203
21. Donders SH, Lustermans FA, van Wersch JW (1993) The effect of microalbuminuria on glycaemic control, serum lipids and haemostasis parameters in non-insulin-dependent diabetes mellitus. Ann Clin Biochem 30:439-444
22. Sumida Y, Wada H, Fujii M et al (1997) Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis 8:303-307
23. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G (1994) PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 43:426-429
24. van Wersch JW, Donders SH, Westerhuis LW, Venekamp WJ (1991) Microalbuminuria in diabetic patients: Relationship to lipid, glyco-metabolic, coagulation and fibrinolysis parameters. Eur J Clin Chem Clin Biochem 29:493-498
25. Anonymous (1997) The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197
26. Bennett PH, Haffner S, Kasiske BL et al (1995) Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25:107-112
27. Handa N, Matsumoto M, Maeda H et al (1990) Ultrasonic evaluation of early carotid atherosclerosis. Stroke 21:1567-1572
28. Wakabayashi I, Masuda H (2006) Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 365:230-235
29. Wakabayashi I, Masuda H (2002) Relation of serum sialic acid to blood coagulation activity in type 2 diabetes. Blood Coagul Fibrinolysis 13:691-696
30. Mertens I, Van Gaal LF (2002) Obesity, haemostasis and the fibrinolytic system. Obes Rev 3:85-101
31. De Pergola G, Pannacciulli N (2002) Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest 25:899-904
32. Bowles LK, Cooper JA, Howarth DJ, Miller GJ, MacCallum PK (2003) Associations of haemostatic variables with body mass index: A community-based study. Blood Coagul Fibrinolysis 14:569-573
33. Yuyun MF, Adler AI, Wareham NJ (2005) What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens 14:271-276
34. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32-35
35. Ritz E (2003) Albuminuria and vascular damage-the vicious twins. N Engl J Med 348:2349-2352
36. Garg JP, Bakris GL (2002) Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 7:35-43